Insight Molecular Diagnostics Inc. - 8-K Filing

Insight Molecular Diagnostics Inc. amended its merger agreement with Chronix Biomedical, modifying earnout terms for CNI Monitor sales and eliminating prior milestone obligations. (Items: 1.01 Entry into a Material Definitive Agreement, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $IMDX

Read the full article at SEC EDGAR

More Regulatory news